Following recent media speculation, Infratil confirms that it is a member of a consortium which is in discussions with Quadrant Private Equity regarding a potential transaction involving an acquisition of a majority interest in Qscan Radiology Clinics, which is a comprehensive diagnostic medical imaging practice throughout Australia. The discussions are ongoing and incomplete and may not result in a transaction occurring.
Infratil notes that it raised additional equity of NZ$300 million in June 2020 to position itself to pursue its growth agenda and take advantage of any other investment opportunities that may arise. The proceeds of the equity raise were initially applied to reduce drawn bank facilities. Those existing bank facilities could now be applied to fund the Qscan acquisition if it occurs, so no additional funding would be required.
We will continue to update the market as material developments unfold.
Any enquiries should be directed to:
Mark Flesher, Investor Relations, Infratil Limited
mark.flesher@infratil.com
Related
ASX Appendix 2A – Dividend Reinvestment Plan
Attached is a copy of ASX Appendix 2A, Application for Quotation of Securities, released to the ASX today. Enquiries should be directed to: Mark Flesher Investor Relations info@infratil.com Authorised for
AUD FX Rate for the FY26 Interim Dividend
Infratil advises that the foreign exchange rate to be used for the Infratil Limited interim dividend to be paid to Australian investors in AUD on 16 December 2025 has been
ASX Appendix 2A – Application for Quotation of Securities
Attached is a copy of ASX Appendix 2A, Application for Quotation of Securities, released to the ASX today.